November 26, 2020

Volume X, Number 331

Advertisement

November 25, 2020

Subscribe to Latest Legal News and Analysis

November 24, 2020

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

Date Title Organization
26
Oct
California Governor Signs Law that Establishes New Safety Standards for Third-Party Food Delivery Applications Keller and Heckman LLP
23
Oct
EFSA Updates Opinion on Styrene in FCMs Keller and Heckman LLP
22
Oct
Japan Announces Process for Adding “Existing Substances” to PL Keller and Heckman LLP
22
Oct
FDA Requests Comments on Labeling Cell-Cultured Seafood Products Beveridge & Diamond PC
22
Oct
China Publishes New Draft GB Standards Related to Food-Contact Materials and Articles Keller and Heckman LLP
22
Oct
Conventional and Cell-Based/Cultured Meat Groups Write Joint Letter to USDA Urging Agency to Solicit Input on What Labeling Should Look Like Keller and Heckman LLP
22
Oct
Gaps in Payment for COVID-19 Laboratory Testing Plague Providers and Patients Polsinelli PC
21
Oct
Drug Manufacturers Unlawfully Target 340B Program Reductions Polsinelli PC
21
Oct
Got COVID-19 “Claims”: Recent US EPA Enforcement under FIFRA Emphasizes Compliance Demands on Pesticide Product Supply Chains, especially for Products Claiming to be Effective against Coronavirus Hunton Andrews Kurth
20
Oct
Bioethics in a Pandemic: Final Framework for Equitable Allocation of a COVID-19 Vaccine Mintz
20
Oct
California Governor Pulls the Plug on Genetic Information Privacy Act Sheppard, Mullin, Richter & Hampton LLP
20
Oct
Study Finds Surge In Misuse of Fentanyl, Heroin and Nonprescribed Opioids During COVID-19 Pandemic Jackson Lewis P.C.
20
Oct
Conagra Slips Away from Parkay Oil Spray Serving Size Claims Proskauer Rose LLP
20
Oct
FDA Announces Establishment of U.S. Agent Voluntary Identification System Keller and Heckman LLP
20
Oct
Life Sciences Newsletter — October 2020 Mintz
19
Oct
China Revamps Food Nutrition Labeling Regulations Keller and Heckman LLP
19
Oct
China Announces Draft GB Standards Related to Food Contact Materials & Articles Keller and Heckman LLP
19
Oct
FDA Issues Final Guidance on Allulose and Solicits Information for Rulemaking on Nutrition Labeling for Sugars That are Metabolized Differently Than Traditional Sugars Keller and Heckman LLP
16
Oct
Proposed Class Action Lawsuit Alleges Ice Cream Producer Falsely Advertised Ice Cream Bars Keller and Heckman LLP
15
Oct
Leaders Moving 2020 Forward - Kimberly Manna, CEO of Panama Jack [VIDEO] McDermott Will & Emery

Pages

Advertisement
Advertisement

TRENDING LEGAL ANALYSIS

Upcoming Legal Education Events

Tuesday, December 8, 2020
Wednesday, December 9, 2020
Wednesday, December 9, 2020
Wednesday, December 9, 2020
Thursday, December 10, 2020
Thursday, December 10, 2020
Thursday, December 17, 2020
Advertisement